Journals Library


Project Published

View Report

  • Latest project information

HTA - 09/92/01

Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Project title: Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Call to action: 14/122 NICE 22nd Wave MTA

Research type: Evidence Synthesis

Chief investigator: Dr Hazel SquiresORCID logoorcid.org/0000-0002-2776-4014

Lead Author: Dr Hazel Squires

Contractor: The University of Sheffield

Co-investigators: Ms Andrea Shippam.

Started: April 2010 | Status: Published December 2011

Study finds that naftidrofuryl oxalate and cilostazol both appear to be effective treatments for adults presenting with intermittent claudication due to peripheral arterial disease with few serious adverse events; however, only naftidrofuryl oxalate is estimated to have an incremental cost per QALY gained below £20,000

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.